131 related articles for article (PubMed ID: 3818259)
1. Direct suppression of antibody responses by chlorinated dibenzodioxins in cultured spleen cells from (C57BL/6 x C3H)F1 and DBA/2 mice.
Holsapple MP; Dooley RK; McNerney PJ; McCay JA
Immunopharmacology; 1986 Dec; 12(3):175-86. PubMed ID: 3818259
[TBL] [Abstract][Full Text] [Related]
2. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro.
Thurmond LM; House RV; Lauer LD; Dean JH
Toxicol Appl Pharmacol; 1988 May; 93(3):369-77. PubMed ID: 2835829
[TBL] [Abstract][Full Text] [Related]
3. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
Snyder NK; Kramer CM; Dooley RK; Holsapple MP
Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
[TBL] [Abstract][Full Text] [Related]
4. Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes.
Morris DL; Jeong HG; Stevens WD; Chun YJ; Karras JG; Holsapple MP
Immunopharmacology; 1994; 27(2):93-105. PubMed ID: 8014031
[TBL] [Abstract][Full Text] [Related]
5. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
[TBL] [Abstract][Full Text] [Related]
6. [Enhanced inhibition of splenic lymphocyte proliferation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57B1/10 (Ah+Ah+) mice compared to DBA/2 (AhAh) mice].
Pavliak AL; Wielgosz SM; Hüttner E
Biull Eksp Biol Med; 1989 Mar; 107(3):331-3. PubMed ID: 2713474
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression without liver induction by subchronic exposure to 2,7-dichlorodibenzo-p-dioxin in adult female B6C3F1 mice.
Holsapple MP; McCay JA; Barnes DW
Toxicol Appl Pharmacol; 1986 May; 83(3):445-55. PubMed ID: 3486501
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte.
Dooley RK; Morris DL; Holsapple MP
Immunopharmacology; 1990; 19(1):47-58. PubMed ID: 2307581
[TBL] [Abstract][Full Text] [Related]
9. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
[TBL] [Abstract][Full Text] [Related]
10. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment in vivo on thymocyte functions in mice after activation in vitro.
Lundberg K; Dencker L; Grönvik KO
Int J Immunopharmacol; 1990; 12(4):459-66. PubMed ID: 1975249
[TBL] [Abstract][Full Text] [Related]
11. Enhanced suppression of humoral immunity in DBA/2 mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Morris DL; Snyder NK; Gokani V; Blair RE; Holsapple MP
Toxicol Appl Pharmacol; 1992 Jan; 112(1):128-32. PubMed ID: 1310164
[TBL] [Abstract][Full Text] [Related]
12. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Tucker AN; Vore SJ; Luster MI
Mol Pharmacol; 1986 Apr; 29(4):372-7. PubMed ID: 3486342
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a complex environmental mixture from the Love Canal.
Silkworth JB; Cutler DS; Sack G
Fundam Appl Toxicol; 1989 Feb; 12(2):303-12. PubMed ID: 2714530
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte.
Dooley RK; Holsapple MP
Immunopharmacology; 1988; 16(3):167-80. PubMed ID: 3267010
[TBL] [Abstract][Full Text] [Related]
15. Interactions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with immune responses of rainbow trout.
Spitsbergen JM; Schat KA; Kleeman JM; Peterson RE
Vet Immunol Immunopathol; 1986 Jun; 12(1-4):263-80. PubMed ID: 3765346
[TBL] [Abstract][Full Text] [Related]
16. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats.
Smialowicz RJ; Riddle MM; Williams WC; Diliberto JJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):248-56. PubMed ID: 8122270
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice.
Thurmond LM; Lauer LD; House RV; Cook JC; Dean JH
Toxicol Appl Pharmacol; 1987 Dec; 91(3):450-60. PubMed ID: 3122368
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in B6C3F1 and DBA/2 mice following single and repeated exposures.
Morris DL; Jeong HG; Jordan SD; Kaminski NE; Holsapple MP
Arch Toxicol; 1998 Feb; 72(3):157-68. PubMed ID: 9520139
[TBL] [Abstract][Full Text] [Related]
19. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on splenic lymphocyte transformation in mice after single and repeated exposures.
Sharma RP; Gehring PJ
Ann N Y Acad Sci; 1979 May; 320():487-97. PubMed ID: 287401
[TBL] [Abstract][Full Text] [Related]
20. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells.
Morris DL; Karras JG; Holsapple MP
Immunopharmacology; 1993; 26(2):105-12. PubMed ID: 8282534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
